Thuja Capital Founded 2006
Founders Harrold van Barlingen
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 31
Rounds per year 2.07
Lead investments 27
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.26
Exits -
Key employees -
Stages of investment
Early Stage Venture
Seed
Areas of investment
Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
Therapeutics
Summary

In 2006 was created Thuja Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Utrecht. The venture was found in Europe in The Netherlands.

The common things for fund are deals in the range of 5 - 10 millions dollars. The top amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Thuja Capital works on 6 percentage points more the average amount of lead investments. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Thuja Capital, startups are often financed by AlpInvest Partners, Oxford Bioscience Partners, Global Life Science Ventures. The meaningful sponsors for the fund in investment in the same round are BOM Capital, Health Innovation Fund, DSM Venturing. In the next rounds fund is usually obtained by Van Herk Ventures, EASME - EU Executive Agency for SMEs, BOM Capital.

The current fund was established by Harrold van Barlingen. Besides them, we counted 2 critical employees of this fund in our database.

The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Curacyte AG, Drug Abuse Sciences, Salvia BioElectronics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
EnCare Biotech
Biotechnology
Medical
Series A
5M21 Nov 2014 Netherlands, Utrecht
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Series A
4M11 Feb 2010 Netherlands, Rotterdam
Galapagos
Biopharma
Biotechnology
Clinical Trials
Medical
Venture - Series Unknown
04 Aug 2007 Japan, Chiyoda
Nightbalance
Biotechnology
Health Care
Home Health Care
Medical
Medical Device
Seed
18 Apr 2011 Netherlands, Delft
Breonics
Health Care
Venture - Series Unknown
01 Mar 2007 United States, City of Watervliet
Curacyte AG
Biotechnology
Venture - Series Unknown
01 Apr 2007 Germany, Munich
Develogen AG
Biotechnology
Health Care
Medical
Therapeutics
Venture - Series Unknown
01 Jun 2007 Germany, Göttingen
EpiCept Corporation
Information Technology
Venture - Series Unknown
03 Aug 2007 United States, Englewood Cliffs
TheraSolve
Health Care
Medical
Venture - Series Unknown
22 Aug 2011 Belgium, Diepenbeek
ATRO Medical
Biotechnology
Health Care
Medical
Medical Device
Series A
17 Jul 2017 Netherlands, Nijmegen
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Thuja Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: